Moeinvaziri Mojdeh, Mansoori Parvin, Holakooee Koorosh, Safaee Naraghi Zahra, Abbasi Ali
Department of Dermatology, Tehran University of Medical Sciences, Razi Hospital, Tehran, Iran.
Acta Dermatovenerol Croat. 2009;17(4):279-84.
The relationship between iron body status and different types of hair loss has been investigated in a number of studies, however, with relatively discrepant findings. Therefore we conducted an analytical case-control study to assess whether diffuse telogen hair loss in women of childbearing age (15 to 45 years old) is associated with iron deficiency. Using the analytical case-control methodology, we studied 30 consecutive women with documented diffuse telogen hair loss in comparison with 30 women without hair loss. Study subjects had no history of nutritional supplement intake or chronic underlying diseases, and had normal thyroid function and inflammatory profiles. Biochemical investigations were performed in all study women. The mean ferritin level and trasferrin saturation was statistically significantly lower in patients with diffuse telogen hair loss than in subjects without hair loss (16.3+/-12.6 vs. 60.3+/-50.1, ng/mL; P<0.0001 and 20.3+/-9.7 vs. 28.3+/-11.8 percent; P=0.006, respectively). Also, total iron binding capacity was significantly higher in patients than in control group (367.8+/-58.2 vs. 319.2+/-60.1 microg/dL; P=0.004). Of nine patients with iron deficiency anemia (Hb <12 g/dL), eight patients had telogen hair loss (odds ratio: 10.5, 95%CI: 1.2-90.7; P=0.013). Odds ratio (95% confidence interval) for diffuse telogen hair loss was 21.0 (4.2-105.0) at serum ferritin levels < or =30 ng/mL. Women with iron deficiency status are at a risk of telogen hair loss. The important role of serum ferritin in hair loss is becoming more evident. In women without systemic inflammation or other underlying disorders, serum ferritin levels below or equal to 30 ng/mL are strongly associated with telogen hair loss.
多项研究对铁储备状态与不同类型脱发之间的关系进行了调查,但结果相对存在差异。因此,我们开展了一项分析性病例对照研究,以评估育龄期(15至45岁)女性的弥漫性休止期脱发是否与缺铁有关。采用分析性病例对照方法,我们研究了30例有记录的弥漫性休止期脱发女性,并与30例无脱发女性进行比较。研究对象无营养补充剂摄入史或慢性基础疾病,甲状腺功能和炎症指标正常。对所有研究女性进行了生化检查。弥漫性休止期脱发患者的平均铁蛋白水平和转铁蛋白饱和度在统计学上显著低于无脱发者(分别为16.3±12.6 vs. 60.3±50.1,ng/mL;P<0.0001;以及20.3±9.7 vs. 28.3±11.8%;P=0.006)。此外,患者的总铁结合力显著高于对照组(367.8±58.2 vs. 319.2±60.1μg/dL;P=0.004)。在9例缺铁性贫血患者(血红蛋白<12 g/dL)中,8例有休止期脱发(比值比:10.5,95%置信区间:1.2 - 90.7;P=0.013)。血清铁蛋白水平≤30 ng/mL时,弥漫性休止期脱发的比值比(95%置信区间)为21.0(4.2 - 105.0)。缺铁状态的女性有休止期脱发的风险。血清铁蛋白在脱发中的重要作用越来越明显。在无全身炎症或其他基础疾病的女性中,血清铁蛋白水平低于或等于30 ng/mL与休止期脱发密切相关。
Acta Dermatovenerol Croat. 2009
J Am Acad Dermatol. 2006-5
Eur J Dermatol. 2007
J Am Acad Dermatol. 2010-10-13
Asia Pac J Clin Nutr. 2004
Skin Appendage Disord. 2022-3
An Bras Dermatol. 2021
Cureus. 2020-5-27
Skin Appendage Disord. 2019-11
Int J Trichology. 2016